CAV-1 in Jak/STAT Signaling, Lactation, & Breast Cancer
Jak/STAT 信号传导、哺乳期中的 CAV-1
基本信息
- 批准号:6569872
- 负责人:
- 金额:$ 37.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-01-23 至 2007-12-31
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis biological signal transduction breast neoplasms caveolins cell line fluorescence microscopy gel mobility shift assay gene mutation gene targeting genetically modified animals hyperplasia immunoprecipitation laboratory mouse lactation membrane proteins neoplastic process phosphorylation polymerase chain reaction prolactin protein structure function tissue /cell culture transfection western blottings
项目摘要
DESCRIPTION (provided by applicant): The long-term objective of this proposal is to understand the role of caveolin-1 in i) Jak/STAT signaling, ii) lactation, and iii) the pathogenesis of breast cancer. Caveolae function as "message centers" for regulating signal transduction. Caveolin-1 (Cav-1) is the principal structural protein of caveolae membranes that are found in most cells. We mapped human CAV-1 to a suspected tumor suppressor locus (7q31.1/D7S522). In addition, the Cav-1 gene is mutated (P132L) in up to 16% of human breast cancers. The aim of this proposal is to test the hypothesis that Cav-1 expression is important for regulating lactation via modulation of Jak/STAT signaling and that loss of Cav-1 contributes to the oncogenicity of breast cancer cells. To test this hypothesis, we will use a variety of complementary in vivo approaches, such as i) a Cav-1 null mouse model and ii) the development of transgenic mice that express dominant-negative Cav-1 (PI32L) found in human breast cancers. The three Specific Aims of the project are: 1) To determine the role of Cav-1 in negatively regulating Jak/STAT signaling. We will examine the effects of Cav-1 on the activation of Jak/STAT signaling in cultured mammary epithelial cells that are responsive to prolactin. Our preliminary results indicate that Cav-1 negatively regulates Jak/STAT5a signaling by inhibiting Jak-mediated phosphorylation of STAT5a; 2) To examine the role of Cav-1 in lactation and epithelial cell hyperplasia. Signaling from the hormone prolactin vial the Jak/STAT pathway controls normal mammary gland development. Thus, if Cav-1 were a negative regulator of Jak/STAT signaling, we would predict that a loss of Cav-1 expression leads to premature lactation. Indeed, our preliminary results show that Cav-1 null mice exhibit premature lactation, as well as hyper-activation of the Jak/STAT5a signaling cascade; and 3) To determine if transgenic expression of Cav-1 (P132L) predisposes towards mammary tumor development. For this purpose, we will generate Cav-1 (P132L) mice that transgenically express this form of Cav-1 in the mammary gland. Our preliminary results indicate that Cav-1 (P132L) acts in a dominant-negative fashion in cultured cells. In addition, our preliminary results with Cav-1 null mice show early development of wide-spread mammary epithelial hyperplasia. We predict that this phenotype will be accelerated Cav-1 (P132L) transgenic mice. We will cross Cav-1 (P132L) transgenic mice with other well-established models of mammary tumorigenesis, such as MMTVErbB2 and MMTV-polyoma middle T mice. It is expected that these studies will contribute fundamental knowledge towards understanding the role of Cav-1 in Jak/STAT signaling and mammary tumorigenesis in vivo.
描述(由申请人提供):本提案的长期目标是了解小窝蛋白-1在i)Jak/STAT信号传导,ii)哺乳和iii)乳腺癌发病机制中的作用。小窝作为调节信号转导的“信息中心”。小窝蛋白-1(Caveolin-1,Cav-1)是存在于大多数细胞中的小窝膜的主要结构蛋白。我们将人CAV-1定位到一个疑似肿瘤抑制基因座(7q31.1/D 7S 522)。此外,Cav-1基因在高达16%的人类乳腺癌中发生突变(P132 L)。该提案的目的是检验Cav-1表达对通过调节Jak/STAT信号传导调节泌乳很重要以及Cav-1的缺失有助于乳腺癌细胞的致癌性的假设。为了检验这一假设,我们将使用各种互补的体内方法,例如i)Cav-1无效小鼠模型和ii)表达在人乳腺癌中发现的显性阴性Cav-1(PI 32 L)的转基因小鼠的开发。本项目的三个具体目的是:1)确定Cav-1在负调控Jak/STAT信号转导中的作用。我们将研究Cav-1对催乳素敏感的培养乳腺上皮细胞中Jak/STAT信号转导激活的影响。我们的初步研究结果表明Cav-1通过抑制Jak介导的STAT 5a磷酸化来负性调节Jak/STAT 5a信号传导; 2)研究Cav-1在哺乳和上皮细胞增生中的作用。来自催乳素小瓶的激素信号传导Jak/STAT途径控制正常乳腺发育。因此,如果Cav-1是Jak/STAT信号传导的负调节因子,我们可以预测Cav-1表达的丧失会导致过早泌乳。实际上,我们的初步结果显示Cav-1缺失小鼠表现出过早泌乳,以及Jak/STAT 5a信号级联的过度激活;和3)确定Cav-1(P132 L)的转基因表达是否倾向于乳腺肿瘤的发展。为此,我们将产生Cav-1(P132 L)小鼠,转基因表达这种形式的Cav-1在乳腺。我们的初步结果表明,Cav-1(P132 L)在培养细胞中以显性负性方式起作用。此外,我们对Cav-1基因敲除小鼠的初步研究结果显示,早期出现广泛的乳腺上皮增生。我们预测这种表型将加速Cav-1(P132 L)转基因小鼠的产生。我们将Cav-1(P132 L)转基因小鼠与其他成熟的乳腺肿瘤发生模型,如MMTVErbB 2和MMTV-polyoma middle T小鼠杂交。预计这些研究将有助于了解Cav-1在体内Jak/STAT信号传导和乳腺肿瘤发生中的作用的基础知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL P LISANTI其他文献
MICHAEL P LISANTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL P LISANTI', 18)}}的其他基金
CAV-1 Epithelial-Stromal Interactions and Breast Cancer
CAV-1 上皮-间质相互作用与乳腺癌
- 批准号:
7261643 - 财政年份:2007
- 资助金额:
$ 37.16万 - 项目类别:
CAV-1 Epithelial-Stromal Interactions and Breast Cancer
CAV-1 上皮-间质相互作用与乳腺癌
- 批准号:
8105212 - 财政年份:2007
- 资助金额:
$ 37.16万 - 项目类别:
CAV-1 Epithelial-Stromal Interactions and Breast Cancer
CAV-1 上皮-间质相互作用与乳腺癌
- 批准号:
7479092 - 财政年份:2007
- 资助金额:
$ 37.16万 - 项目类别:
CAV-1 Epithelial-Stromal Interactions and Breast Cancer
CAV-1 上皮-间质相互作用与乳腺癌
- 批准号:
7667735 - 财政年份:2007
- 资助金额:
$ 37.16万 - 项目类别:
CAV-1 Epithelial-Stromal Interactions and Breast Cancer
CAV-1 上皮-间质相互作用与乳腺癌
- 批准号:
7880060 - 财政年份:2007
- 资助金额:
$ 37.16万 - 项目类别:
CAV-1 in Jak/STAT Signaling, Lactation, & Breast Cancer
Jak/STAT 信号传导、哺乳期中的 CAV-1
- 批准号:
7161739 - 财政年份:2003
- 资助金额:
$ 37.16万 - 项目类别:
CAV-1 in Jak/STAT Signaling, Lactation, & Breast Cancer
Jak/STAT 信号传导、哺乳期中的 CAV-1
- 批准号:
7290102 - 财政年份:2003
- 资助金额:
$ 37.16万 - 项目类别:
CAV-1, Stat5a Signaling, and Estrogen-Dependent Breast Cancer
CAV-1、Stat5a 信号传导和雌激素依赖性乳腺癌
- 批准号:
7743796 - 财政年份:2003
- 资助金额:
$ 37.16万 - 项目类别:
CAV-1 in Jak/STAT Signaling, Lactation, & Breast Cancer
Jak/STAT 信号传导、哺乳期中的 CAV-1
- 批准号:
7001321 - 财政年份:2003
- 资助金额:
$ 37.16万 - 项目类别:
CAV-1, Stat5a Signaling, and Estrogen-Dependent Breast Cancer
CAV-1、Stat5a 信号传导和雌激素依赖性乳腺癌
- 批准号:
7559728 - 财政年份:2003
- 资助金额:
$ 37.16万 - 项目类别:
相似海外基金
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
6238317 - 财政年份:1997
- 资助金额:
$ 37.16万 - 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
5210031 - 财政年份:
- 资助金额:
$ 37.16万 - 项目类别: